Winton Group LTD Revolution Medicines, Inc. Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$24.35 - $33.7 $252,022 - $348,795	-10,350 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$23.95 - $33.41 $128,132 - $178,743	-5,350 Reduced 34.08%	10,350 $285,000
Q2 2021 Aug 10, 2021	BUY	$29.0 - $47.44 $113,883 - $186,296	3,927 Added 33.36%	15,700 $498,000
Q1 2021 Jul 21, 2021	BUY	$37.21 - $54.43 $175,593 - $256,855	4,719 Added 66.9%	11,773 $540,000
Q4 2020 Feb 12, 2021	BUY	$30.19 - $45.49 $212,960 - $320,886	7,054 New	7,054 $279,000

272

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.53B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.